Glenmark Pharma gets USFDA nod for prostate cancer treatment drug

Glenmark Pharma gets USFDA nod for prostate cancer treatment drug

"Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food Drug Administration (USFDA) for Abiraterone Acetate tablets USP, 250 mg," the company said in a regulatory filing.

Read More